ONO Transcatheter Retrieval System
Percutaneous removal of embolized/malpositioned cardiovascular devices (e.g., LAAO occluders)
Key Facts
About ONOCOR
ONOCOR Vascular is a clinical-stage medical device company addressing a critical complication in the rapidly growing field of catheter-based structural heart interventions: the need to retrieve suboptimal or embolized implants. The company's lead product, the ONO transcatheter retrieval system, is designed to safely and reliably receive, align, compress, and remove devices like left atrial appendage occlusion (LAAO) plugs through a minimally invasive approach. With a first-in-human case successfully published in 2024, ONOCOR is positioned to capitalize on the expansion of transcatheter therapies by offering a specialized tool that could improve procedural safety and expand patient eligibility. The company is led by a team of physician co-founders and an experienced CEO, operating as a private, pre-revenue entity.
View full company profile